Research programme: phosphodiesterase IV inhibitors - deCODE geneticsAlternative Names: DG 071; PDE4B inhibitors - deCODE genetics; PDE4D inhibitors - deCODE genetics
Latest Information Update: 30 Jan 2013
At a glance
- Originator deCODE genetics
- Class Small molecules
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors; Type 4 cyclic nucleotide phosphodiesterase modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- Available For Licensing Yes
Highest Development Phases
- Suspended Alzheimer's disease; Asthma; Chronic obstructive pulmonary disease; Stroke; Vascular disorders